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Abstract
Background: The TF (Thomson – Friedenreich) blood group antigen behaves as an onco-foetal carcinoma-associated antigen,
showing increased expression in malignancies and its detection and quantification can be used in serologic diagnosis mainly in
adenocarcinomas. This study was undertaken to analyze the sera and tissue level detectable mucin-type glycoprotein (TF-
antigen) by Peanut agglutinin (PNA) and its diagnostic index in serum as well tissues of human esophageal squamous cell
carcinoma as marker.
Results: We examined 100 patients for serological analysis by Enzyme Linked Lectin Assay (ELISA) and demonstrated a
sensitivity of 87.5%, specificity of 90% and a positive predictive value of 95%. The immuno-histochemical localization of TF
antigen by Fluorescence Antigen Technique (FAT) in 25 specimens of normal esophageal squamous epithelium specimens and
92 specimens with different grades of, allowed a quicker and more precise identification of its increased expression and this did
not correlate with gender and tumor size. There was a positive correlation between membrane bound TF antigen expression
with different histological progression, from well differentiated to poorly differentiated, determined by PNA binding. Specimens
showed morphological changes and a pronounced increase in PNA binding in Golgi apparatus, secretory granules of the cytosol
of well differentiated and an increased cell membrane labeling in moderately and poorly differentiated, when compared with
ESCC and normal tissues.
Conclusion: The authors propose that the expression of TF-antigen in human may play an important role during tumorigenesis
establishing it as a chemically well-defined carcinoma-associated antigen. Identification of the circulating TF-antigen as a reactive
form and as a cryptic form in the healthy individuals, using PNA-ELLA and Immunohistochemical analysis of TF antigen by FAT
is positively correlated with the different histological grades as a simple and cost-effective method for the early diagnosis of
ESCC. The present study reveals that, during tumorigenesis, an aberrant glycosylation takes place in Golgi apparatus leading to
over secretion of TF antigen into the cytoplasm along with mucin granules and later into cell membrane. We suggest that the
further characterization of TF antigen may unravel pathogenetic aspects of this silent disease.
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Background
Synthesis and secretion of mucin are common features of
glandular epithelial tissues and the expression of mucin
antigens has been investigated mainly in adenocarcino-
mas [1]. Under certain pathological conditions, particu-
larly during the course of carcinogenesis, their
biosynthesis is altered with regard to the rate of produc-
tion and the degree of glycosylation, also in squamous cell
carcinomas [2,3]. Oncogenic transformation is often asso-
ciated with changes in glycosylation in either glycolipids
or glycoproteins in cell membranes. This leads to the
incomplete glycosylation of the core carbohydrate struc-
tures resulting in the formation of T, Tn and sialyl Tn anti-
gens in a variety of cancers [2,4]. Among them, TF-antigen
was found to be a pan-carcinoma marker, i.e., it is
expressed by a variety of cancers derived from different tis-
sues [3] and it has been targeted recently for the develop-
ment of tumor selective vaccines [5].
The circulating levels and cell membrane localization of
TF-antigen involves the binding of lectin PNA, a non-toxic
TF-antigen binding lectin [6,7], which can covalently bind
to the Galβ1–3 GalNAc residue of the TF-antigen. Among
various lectins, peanut agglutinin (PNA), is the most
widely used to identify new diagnostic and prognostic
markers in various squamous cell carcinomas [2,3,8].
Esophageal cancer is the sixth most frequent cause of can-
cer death worldwide. Invasive esophageal cancer is a
multistage progressive process, which involves the conver-
sion of normal epithelium to basal cell hyperplasia
(BCH), dysplasia (DYS) or carcinoma in situ (CIS), and
then to invasive squamous cell carcinoma. In all these
steps there is an interaction between the tumor cell surface
and neighboring cells [9], which may be important in the
very early stage of the metastatic process of ESCC.
Recently, more attention has been paid towards the TF-
antigen expression in carcinomas [4,8,10]. The aim of the
present study was to determine the TF antigen levels and
to define the relationship between circulating levels of TF-
antigen with different histological grades of ESCC by
using the Galβ1–3 GalNAc-specific lectin, PNA [2,10,11].
Results and Discussion
Blood TF-antigen of patients and its relation to the 
histological grades
A total of 100 patients consisting of 64 males and 36
females were taken in this study. Their age varied from 31
to 84 years with a mean age of 52 years. Of the hundred
patients (ESCC), 18 were classified as well differentiated
(WD), 50 as moderately differentiated (MD) and 32 as
poorly differentiated (PD) esophageal squamous cell car-
cinoma (group II). The results confirm the expression of
TF-antigen irrespective of the histological differentiation.
The level of expression was observed from OD 0.218 to
0.571. Circulating PNA-binding mucin levels were
increased in all histological grades of the patients (Table 1
and Figure 1). When OD of 0.159 (Mean OD in normal +
2 standard deviation) was taken as the normal upper
limit, PNA/ELLA had a sensitivity of about 87.5% for
ESCC patients (Table 2). There was no significant reduc-
tion of TF-antigen in group III patients when compared
with the group II patients, who received therapy.
This study is the first to show the presence of PNA-binding
mucin-type glycoprotein in ESCC sera. The infiltrating
growth, the mass or the tumor volume and the degree of
histological differentiation of tumor may influence serum
value of TF-antigen in this study. This suggests that well
differentiated ESCC does not contain more circulating TF-
antigen. The present results of circulating TF-antigen levels
in different histological grades of ESCC patients are simi-
lar in terms of intense cytoplasmic and membrane associ-
ated TF-antigen expression in in situ carcinomas of colon
and ovary. Accordingly, Lin et al [15] and Lalwani et al
[16] observed a gradual loss of blood group antigens A, B
and H in many of the squamous cell carcinomas of the lar-
ynx and this gradual loss parallels morphologic transfor-
mations from normal squamous mucosa to various stages
of intra-epithelial interactions and finally to overt carci-
noma [15]. Shamsudhin et al [17] also reported that
malignant transformation of the colon may be accompa-
nied by alterations in carbohydrate production as
observed in the present study.
Table 1: Serum Gal/GalNAc estimation by PNA/ELLA in ESCC 
(Upper limit of normal = 0.159 A450)
Parameters Group No. Patients Mean O.D ± S.D.
Gal/GalNAc I Normal 50 0.071 ± 0.044
II WDESCC 18 0.349 ± 0.131*
MDESCC 50 0.402 ± 0.169*
PDESCC 32 0.392 ± 0.171*
III WDESCC 11 0.319 ± 0.142*
MDESCC 47 0.411 ± 0.119*
PDESCC 25 0.319 ± 0.149*
Gal/GalNAc – Galactose β-1, 3-α, N-acetyl galactosamine PNA/ELLA 
– Peanut Agglutinin/Enzyme Linked Lectin Assay ESCC – Esophageal 
Squamous Cell Carcinoma OD – Optical Density Group I – Healthy 
volunteers Group II – Before therapy WDESCC – Well Differentiated 
Esophageal Squamous Cell Carcinoma MDESCC – Moderately 
Differentiated Esophageal Squamous Cell Carcinoma PDESCC – 
Poorly Differentiated Esophageal Squamous Cell Carcinoma Group III 
– After therapy * (P < 0.05) Significant of group II and III against group 
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This suggests that in normal cells the TF antigen is cryptic,
whereas in malignant tumors, deficient glycosyltrans-
ferase activity, may lead to their exposure and during fur-
ther advancement of the cancer, the O-linked
carbohydrates may be drastically altered on the cell mem-
brane [18]. The present result suggests that malignant
transformation in ESCC was accompanied by the
increased addition of galactose to the α-N-acetyl galactos-
amine O-linked carbohydrate core on the cell membrane.
Lectin Histochemical Analysis for Membrane bound TF 
Antigen Expression
The TF antigen was expressed in all patients irrespective of
the stage of the development. The degree of expression,
classified as mild, moderate and intense, correlated with
different histological grades of ESCC. Of the total 92
patients the expression of TF antigen was mild in 21
patients (about 23%), moderate in 32 patients (about
35%) and intense in 39 patients (about 42%) (Table 3).
Of the 21 patients who showed mild expression, 10 were
graded as WD, 8 were graded as PD and the remaining
three were graded as MD. Though, one expects mild anti-
gen expression in WD patients who were in MD and PD
also showed mild expression (about 52%). Similarly, one
expects moderate and intense expression being associated
with MD and PD patients. Even in this instance, 13
patients, who were in WD, showed moderate to intense TF
antigen expression.
Of the total 71 patients whose TF antigen expression was
moderate and intense in 13 patients were histologically
classified as WD. This works out to about 18% of the
patients with moderate and intense expression. These
patients constitute about 57% of the WD patients. For
example, about 43% of WD patients showed mild expres-
sion. In contrast, the proportion of the patients who
showed intense expression between MD and PD were
52% and about 55%, respectively (Table 3). It appears
that there is no linear dependence of TF antigen expres-
sion with the histological grades. In spite of these discrep-
ancies, there is a good correspondence between different
PNA/ELLA levels in ESCC and normal Figure 1
PNA/ELLA levels in ESCC and normal. 0.187 (A405) is 
chosen as the upper limit of normal (Normal (red), Before 
treatment (green), after treatment (violet)). The number of 
patients is given in parenthesis.
Table 2: Assessment of usefulness of Gal-GalNAc as tumour 
marker by PNA/ELLA
PNA/ELLA Upper limit of normal (O.D) = 
0.159 (A450)
WDESCC MDESCC PDESCC All 
patients
Sensitivity (%) 88.9 86.0 87.5 87.5
Specificity (%) 90.0 90.0 90.0 90.0
Positive 
predictive 
value (%)
76.2 89.6 84.9 94.6
Negative 
predictive 
value (%)
95.8 86.6 91.8 77.6
Table 3: Fluorescent Antibody Technique (FAT) showing TF-
antigen expression in ESCC
Histologic
al Grade
N Mild + n 
(%)
Moderate 
++ n (%)
Intense 
+++ n (%)
WDESCC 23 10(43.48) 11(47.83) 2(8.70)
MDESCC 25 3(12.0) 9(36.0) 13(52.0)
PDESCC 44 8(18.18) 12(27.27) 24(54.55)
Total 92 21(22.82) 32(34.78) 39(42.39)
WD: Well differentiated, MD: Moderately differentiated, PD: Poorly 
differentiated ESCC and N: Number of patients.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/38
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histological grades and TF antigen expression in the sam-
ples investigated.
In the lectin histochemical analysis for TF-antigen via PNA
display many of the properties of an antibody in that they
are capable of interacting with a restricted group of
polysaccharides [19–21], and this method may become a
routine procedure in laboratories concerned with identifi-
cation and characterization of mucin type antigen. There
are no specific and efficient antibodies to perform
immuno histochemistry, based on the protein backbone
of the mucins. The results of the fluorescent antibody
analysis on tissues of ESCC patients suggest that PNA may
be used for TF antigen detection, because quantification
of gene products by immunohistochemistry and other
immunologic means using antibodies is often difficult,
owing to the heavy glycosylation of the mucoprotein
which precludes effective binding of antibodies [22]. In
addition, PNA binding to TF antigen indicates the pres-
ence of the disaccharide Gal 1,3-GalNAc. The lectin-bind-
ing characteristic of this marker and its high molecular
weight suggests that it is a mucin-type glycoprotein.
Ultrastuctural Modifications During TF-antigen formation
Squamous cells lined the morphology of the normal
esophageal mucosa and intercellular bridges could be
observed (Figure 2A), whereas in ESCC, the cells were
necrotic with serrated cell membrane and enlarged nuclei.
The margins of the nuclei were irregular and prominent
(Figure 2B).
Morphological alterations of normal and carcinoma cells of esophagus Figure 2
Morphological alterations of normal and carcinoma cells of esophagus. A. Electron micrograph showing normal 
mucosal squamous cells with centrally placed oval nucleus (Uranyl acetate and lead citrate staining. Bar scale = 5 µm). B. Elec-
tron micrograph of WD showing neoplastic squamous cells with large irregular nucleus and serrated cell borders (Uranyl ace-
tate and lead citrate staining. Bar scale = 5 µm).Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/38
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Intracellular Expression
On examination of ESCC for TF antigen expression by
immunogold labeling, a pronounced difference in the cell
surface labeling was observed when compared to normal
squamous epithelium (Figure 3A &3B). Densely labeled
PNA-embedded mucin granules were observed in the
cytosol of WD (Figure 3C,3D,3E &3F), whereas in moder-
ate and poorly differentiated, abundant labeling was
observed in the cell membrane.
Immunogold labeling was higher in early differentiation
of cancer development (WD) and was usually detected
over the trans-cisternae trans-Golgi network and vacuoles,
in addition to lower labeling in the plasma membrane of
WD (Figure 3C, 3D &3E). Whereas, higher intensity of
PNA labeling was observed in the plasma membrane of
moderately and poorly differentiated (Figure 3B)
suggesting that the intensity of PNA labeling from cytosol
to plasma membrane increased with disease progression.
In normal tissue sections the PNA labeling was very low,
when compared to other grades of (Figure 3A &3B).
Increased expression of TF antigen (Gal β1–3 GalNac α-)
in cytosol of WD (Figure 3C) and on cell membrane of
MD and PD (Figure 4) was observed when compared with
normal squamous epithelium (Figure 2A &4B).
In the present study the ultra structural localization of the
TF antigen was observed to be more in WD mostly con-
fined to the golgicisternae, cytosol and secretory mucin
granules. In MD and PD the localization was found to be
less in the cytosol than in WD whereas it was present
mostly in the cell membrane. However, slightly more
immune reactivity of TF antigen with PNA was observed
in the intercellular spaces of poorly differentiated ESCC. It
has recently been shown that the use of PNA against
tumor-associated antigens in several cancer patients
produced consistent results in the cancer of breast [4],
ovary [23,24] and colon [8,19,25]. The synthesis and
expression of TF antigen in ESCC patients was not reduced
even after therapy. Aberrant glycosylation involves incom-
plete synthesis resulting in deletion of normally expressed
antigens, with or without, exposure of core sugar and pep-
tide structures. Inappropriate expression of antigenic
structures, which are not normally present, are O-glyco-
sidically linked through GalNAc to Thr/Ser. These carbo-
hydrate side chains may be divided into core, backbone
and peripheral regions. All three regions provide a specific
recognition site for antibodies and lectins. Such aberra-
tions in cell surface glycoproteins, especially the carbohy-
drates are associated frequently with altered adhesion,
cell-cell interactions and in signal transduction pathways
[22,26–28].
WD expressed higher immunoreactivity in the cytosol
(Figure 3D &3E) when compared with the poorly and
moderately differentiated esophageal carcinoma where
the immune reactivity was higher in the cell membrane
for mucin expression. Similar observations were reported
for oral cancer [2,20]; breast cancer [29] and cancer of
uterine cervix [24,30].
Glycoproteins are being used frequently for diagnostic
and prognostic purposes in squamous cell carcinoma
[4,23]. The carbohydrate moieties of glycoproteins on cell
surfaces play an important role in intercellular recogni-
tion, adhesion and morphogenesis during oncogenesis,
because these glycoproteins function as the major recep-
tors for extra-cellular matrix proteins and as cell adhesion
molecules, related to the regulation of numerous cellular
biological processes including embryonic development
[31]. Aberrant glycosylation of proteins is a common
feature found in ESCC patients [28] and aberrations in
adhesive interactions can lead to pathological disorders
[26]. The positive detection of PNA binding TF-antigen in
peripheral blood sample, agrees well with earlier data on
the loss of polarity and shedding of mucin into the circu-
lation by abnormal glycosylation of cell surface glycopro-
tein during tumorigenesis [8,24,26,31]
Recently, it has been reported that a high percentage of
ESCC expressed MUC1 and MUC4 genes [32,33]. The
expression of mucin genes or proteins in adenocarcinoma
is not totally unexpected, although heterogenecity of
expression was observed in tumors of [28,33]. Dysregu-
lated expression of both membrane-bound and secreted
mucin core protein epitopes, presumably due to both
altered mucin mRNA levels and altered mucin glycosyla-
tion during neoplastic transformation in [33] leads to the
heterogenecity of mucin core protein, which fails to recog-
nize the monoclonal antibodies. There are 7 different
anti-TF antibodies, [TF2 (human), TF5 (human), 5A8
(mouse), 8D8 (mouse) and BM22 (mouse), TF1
(human), 49H.9 (mouse), HT-8 (human) and RS1-114
(mouse)] available for the recognition of tandem repeats
of mucin core protein as epitopes on TF-antigen [6,10],
none of them have shown any correlation between bind-
ing pattern and clinico-pathological variables, such as
TNM stage, lesions of lymph node and grading for TF-
antigen [34]. Whereas, the expression of the reactive form
of TF-antigen in ESCC and cryptic form in healthy individ-
uals probed by PNA may provide a distinct advantage over
the use of monoclonal antibodies for the detection of TF-
antigen as a diagnostic marker.
In conclusion, an enzyme-linked (peanut) lectin binding
assay (PNA/ELLA) could be effectively employed in
detecting tumor-related glycoproteins present in the sera
of patients with ESCC. It is reproducible and easy to per-
form with a sensitivity of 86 percent and specificity of 90
percent. The study thus establishes the presence of aMolecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/38
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Altered expression of TF antigen in carcinoma cells Figure 3
Altered expression of TF antigen in carcinoma cells. A Normal esophagus: Electron micrograph showing lesser expres-
sion of TF antigen along the cell membrane (Uranyl acetate and lead citrate staining. Bar scale = 250 nm). B. WD: Electron 
micrograph showing increased TF antigen expression embedded in the mucinous secretion (Uranyl acetate and lead citrate 
staining 200 nm). C. WD: Electron micrograph showing cytosol of neoplastic cells with scattered TF antigen expression (Ura-
nyl acetate and lead citrate staining. Bar scale = 250 nm). D. WD:Electron micrograph showing TF antigen positive granules in 
the near vicinity of mucin in the cytosol (Uranyl acetate and lead citrate staining. Bar scale = 500 nm). E. WD: Electron micro-
graph showing TF antigen positive granules embedded in the mucin (Uranyl acetate and lead citrate staining. Bar scale = 200 
nm). F. WD: Electron micrograph showing TF antigen positive granules abundantly embedded in the mucin (Uranyl acetate and 
lead citrate staining. Bar scale = 250 nm).Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/38
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chemically well-defined carcinoma-associated antigen in
the sera of ESCC patients. Therefore, the quantitative esti-
mation of TF-antigen by PNA-ELLA method can be used
as a non-invasive technique for rapid screening for early
detection of tumorigenesis and tumor progression.
The immunohistochemical method using lectins displays
many of the properties of an antibody in that lectins are
capable of interacting with a restricted group of polysac-
charides [10,14] and this method may become a routine
procedure in laboratories concerned with identification
and characterisation of mucin type antigen. Identification
of mucin-type glycoprotein by antibodies is often diffi-
cult, owing to the heavy glycosylation of mucoprotein,
which precludes effective binding by the antibodies [14].
The synthesis of TF antigen is based on the composition
of ser/thr, where the addition of GalNAc to the predeter-
mined peptide occurs in the cis-golgi, while galactose is
added in the trans-golgi network by glycosyltransferases
[35]. In the present study, lectin histochemistry by elec-
tron microscopy using biotinylated PNA, has also
revealed the precise localization of TF-antigen in the trans-
golgi apparatus of (Figure 3C).
Thus, during tumorigenesis, changes in the glycosylation
at golgi apparatus led to the over secretion of TF antigen
into the cytoplasm. Later, it may be transported to the cell
membrane and released into the blood stream through
secretory granules or embedded in the mucus layer in an
aberrantly glycosylated form [24,36]. The present results
also suggest that malignant transformation in the squa-
mous cells of esophagus was accompanied by the
increased expression of TF antigen when compared to the
normal esophageal squamous cells. These findings are
similar to those reported earlier for the colon, endothelial
metastasis and parietal cells of the stomach [19,37].
The expression of TF-antigen in adenocarcinoma is not
totally unexpected [38], because the synthesis and secre-
tion of mucins is a common feature of glandular epithelial
tissues [39]. Normal squamous cells do not secrete
mucins [37], but they were observed in the ESCC [33] and
circulating blood of cervical SCC patients [24].
Conclusion
This study has provided strong evidence for the genesis
and expression of TF-antigen in the golgi apparatus,
mucin granules in the cytosol of WD and cell membrane
of MD and PD, confirmed by PNA in histological classifi-
cation of ESCC. The above observations indicate that
changes occur in intracellular glycoconjugates during, or,
after malignant transformation. ELLA and Immuno
histochemical analysis of TF antigen by FAT is positively
correlated with the different histological grades of ESCC
as a simple and cost-effective method for the early diagno-
sis of human ESCC.
Materials and methods
Patients, Sera and Tumor tissues collections
The study was carried out on human Esophageal Squa-
mous Cell Carcinoma patients [before therapy (group II)
and after therapy (group III)], who were receiving treat-
ment from 1996 to 2000 at Barnard Institute of Radiology
and Oncology and Institute of Pathology, Chennai Medi-
cal College and Research Institute (CMC&RI), Chennai,
India. The samples were classified according to the system
of the World Health Organization (WHO) [12], after
obtaining clearance from the ethical board of the hospital
Formation of altered TF antigen in ESCC Golgi apparatus Figure 4
Formation of altered TF antigen in ESCC Golgi appa-
ratus. A Electron micrograph of normal squamous cell 
showing weak TF antigen expression (Uranyl acetate and 
lead citrate staining. Bar scale = 200 nm). B. Electron micro-
graph of neoplastic squamous cell of the cisternae of Golgi 
apparatus showing abundant gold labeling for increased TF 
antigen (Uranyl acetate and lead citrate staining. Bar scale = 
500 nm).Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/38
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on recommendation of the physicians attached to the
above departments. The grades of histological differentia-
tion of the ESCC were classified according to the criteria
of the World Health Organization [12] because the TNM
classification was not possible for staging most of the
unresectable and MD or PD. Serum was also obtained
from 50 healthy volunteers (Group I) matched for age for
comparative purpose.
Enzyme Linked Lectin Assay (ELLA)
ELLA was performed with PNA (Purchased from Sigma
USA), by the method of Zhuang [13]. The diluted serum
(1:200) in carbonate-bicarbonate buffer (pH 7) was
coated in 96 well flat bottom microtitre Figures, incubated
at 4°C for 12 hrs and washed with phosphate buffered
saline-Tween20 (PBST). Nonspecific sites were blocked
with 0.1% bovine serum albumin (BSA) for 1 hr at 37°C,
and washed with PBST. 100 µl of the serially diluted PNA
(5 µg/ml) in lectin buffer pH 7.6 containing 50mM Tris;
150 mM NaCl; 3.3 mM MgCl2 and 1.3 mM CaCl2 (pH 7.6)
was added to the wells, incubated for 1 hr at 37°C and
washed once with PBST. The anti-PNA was diluted
(1:5000) in PBS and 100 µl was added to each well, incu-
bated at 37°C. After washing the wells with PBS, 100 µl of
goat anti-rabbit IgG horse radish peroxidase conjugate
was added and incubated for 1 hr at 37°C. After washing
with PBS, freshly prepared substrate (0.75 mg/ml diami-
nobenzidine in PBS containing 0.03% H2O2) was added
for color development. The reaction was arrested by add-
ing 3N H2SO4 and read at 405 nm in a multiscan ELISA
reader. Appropriate positive (serum of ESCC patients) and
negative (normal serum) controls were maintained. The
mean value of normal (N) added with two standard devi-
ation (2SD) of normal was taken as positive (P) for ESCC
i.e., N + 2SD = P.
Light microscopical Detection
ESCC specimens were obtained from 92 patients (with
different histological grades of ESCC) who underwent
treatment at the Department of Medical and Surgical Gas-
troenterology and Institute of Pathology, CMC & RI. Biop-
sies were taken from 25 normal areas (200 mm) of
squamous esophageal mucosa distant from the ESCC of
the same patients. These biopsies were fixed under the
same conditions as biopsies of ESCC regions. Paraffin
embedded tissues (5 µm thick) were stained with haema-
toxylin and eosin and periodic acid-Schiff reagent to
detect the grade of histological differentiation in the ESCC
group and subjected for histological analysis if TF antigen.
Lectin Immunohistochemistry (Florescent Antibody 
Technique-FAT)
PNA binding analysis was carried out according to the
method of Brooks et al [14] with slight modifications.
Deparaffinised and rehydrated sections of all groups were
transferred to lectin buffer for 10min at room tempera-
ture. Then, the sections were exposed to PNA (5 µg/ml)
for one h and rinsed thrice in lectin buffer pH 7.6. Subse-
quently, the sections were incubated with anti-PNA
(1:1000) for 30 min. and with FITC labeled Goat anti-rab-
bit IgG (1:5000) for 30 min and washed 3× for 5 min.
each. Finally, the sections were gently rinsed in tap water
and observed under a fluorescence microscope at 492 nm.
Sections were also processed in the absence of lectin in
order to exclude the non-specific interaction of anti-PNA
to cells.
Assessment of Immuno histo-chemistry and Statistical 
analysis
The approximate percentages of fluorescence in normal
and neoplastic cells were scored. The intensity of the
membrane bound TF antigen for PNA binding was
qualitatively expressed in three grades depending upon
the proportion of fluorescence on neoplastic cells as fol-
lows: 1+, mild (1–25% staining of neoplastic cells) 2+,
moderate (25–50% staining of neoplastic cells) and 3+,
intense (>50% staining of cells). Qualitative data were
analyzed by correlation co-efficient test. P < 0.05 was con-
sidered as significant and to predict the clinical progres-
sion of the disease.
Electron microscopy
Ten fresh biopsies of each histological grade were received
from the Department of Medical Gastroenterology, from
patients with ESCC. Biopsies were also taken from normal
areas of squamous esophageal mucosa, distant from the
tumor region. Transmission electron microscopic (TEM)
analysis was carried out on the normal and ESCC speci-
mens for the comparison of morphological changes at the
cellular level. Different histological grades of biopsy spec-
imens, determined through haematoxylin and eosin
staining to locate the target region, were washed in saline
and fixed in, 2.5% glutaraldehyde at room temperature,
over night. They were later fixed in 1% osmium tetraoxide
for 2 h at 4°C and dehydrated in acetone for 30 min
(twice). The dehydrated samples were treated with tolu-
ene for 30 min (twice) for clearing and embedded in pure
embedding medium using gelatin flat embedding moulds
for the orientation of specimen. Embedded blocks were
kept at 50°C for polymerization (overnight). Semi thin
sections (from normal and ESCC blocks) were stained
with methylene blue and tumor regions from the blocks
were selected for ultra structural examination. Sections
(60 nm thick) were routinely contrasted with uranyl ace-
tate and lead citrate before being observed under the
Transmission Electron Microscope (TEM Philips 10) at
EM facility AIIMS, New Delhi, India.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/38
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Immunoelectron microscopy (IEM)
Desired regions of the normal and ESCC tissues were fixed
in 0.3% glutaraldehyde, 2% formaldehyde (v/v) for 15
min, followed by two washes in PBS at room temperature.
Dehydration of the fixed tissue was performed in ethanol
and infiltrated with 1:1 mixture of 100% acetone and
Lowicryl white resin twice (1 h each) and placed in resin
filled capsules for block making. Polymerization was per-
formed for 18 h at 60°C. Gold particles as electron dense
markers conjugated with streptavidin were used as probe
to localize the antigenic site in the specimens.
TF antigen detection by biotin labeled PNA
Ultra thin sections (90 nm) on the grids were treated with
blocking buffer for 15–20 min followed by biotinylated
PNA for 3 h and washed 3× with lectin buffer and were
exposed to Streptavidin – Gold conjugate for 2 h. The
grids were then washed 3× in lectin buffer and stained for
observation.
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